ASH 56th (2014)

Drupal spam blocked by CleanTalk.
Title Content type
Primary treatment of invasive mucormycosis (IM) with Isavuconazole (VITAL study) or amphotericin formulations (FungiScope™): Case matched analysis (click for details)
Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation (click for details)
Cerebral Arterial Velocities in SCA-Children with Abnormal Doppler Are Reduced and Normalized More Frequently after Transplantation Than after Transfusion Program (French National Trial “Drepagreffe” AP-HP N°: NCT 01340404) (click for details)
Influence of Preexisting Invasive Aspergillosis on Allo-HSCT Outcome: A Retrospective EBMT Analysis from the Infectious Diseases and Acute Leukemia Working Parties (click for details)
Analysis of Major Infection Risk in 706 Patients with Chronic Lymphocytic Leukemia (click for details)
A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis (click for details)
Infections in Patients with Myelodysplastic Syndrome/Acute Myeloid Leukemia Treated with Azacitidine: Report from a Single Center (click for details)
Prophylaxis of Invasive Pulmonary Aspergillosis with Nebulized Lipid Complex Amphotericin B Is Feasible, Well Tolerated and Safe in Children with Acute Leukemia. Results of a Phase II Open Trial (click for details)
Major Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors (click for details)
Evaluation of Azacitidine Clinical Efficacy in Patients with Myelodysplasia Syndrome Dudina G.a., Golenkov a.K., Kataeva E.V., Mitina T.a. Moscow Regional Clinical Research Institute (click for details)


Subscribe to ASH 56th (2014)